Figure 2
From: IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia
Rituximab treatment has complex effects on IgG1-Fc glycosylation. Paired samples of immune thrombocytopenia patients (N = 41) were assessed before and 60 days after rituximab treatment. Data are individual patient measurements (mean ± SEM). p-values are given for a paired t-test, corrected for multiple comparisons.
